l 694247 has been researched along with lisuride in 1 studies
Studies (l 694247) | Trials (l 694247) | Recent Studies (post-2010) (l 694247) | Studies (lisuride) | Trials (lisuride) | Recent Studies (post-2010) (lisuride) |
---|---|---|---|---|---|
32 | 0 | 8 | 756 | 80 | 31 |
Protein | Taxonomy | l 694247 (IC50) | lisuride (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.02 | |
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.041 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.559 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0003 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.016 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0029 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0005 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0043 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0005 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.173 | |
Histamine H2 receptor | Homo sapiens (human) | 1.04 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.041 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.003 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.02 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0005 | |
Histamine H1 receptor | Homo sapiens (human) | 0.16 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0002 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0051 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audinot-Bouchez, V; Chaput, C; Conte, C; Lavielle, G; Lochon, S; Millan, MJ; Newman-Tancredi, A; Verrièle, L | 1 |
1 other study(ies) available for l 694247 and lisuride
Article | Year |
---|---|
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Cell Membrane; Cricetinae; Dihydroergotamine; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; In Vitro Techniques; Indoles; Lisuride; Methysergide; Migraine Disorders; Piperazines; Piperidines; Pizotyline; Propranolol; Propylamines; Protein Binding; Pyridines; Pyrimidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 1997 |